3Q23 & 9M23 Performance Overview

Externally valued¹ HOSPITALS BUSINESS VALUATION OVERVIEW VALUE DEVELOPMENT OVERVIEW | 3Q23 (GEL MILLION) Change q-o-q -5.2% +3.9% 0.0% -10.4% 681 645 (35) 382 (231) (33) IMPLIED LTM EV/EBITDA DEVELOPMENT 12.9x 12.5x Enterprise value 30-Jun-23 Net decrease in EV Enterprise value 30-Sep-23 Net debt inc. Lease liabilities Minority interest Equity value 30-Sep-23 30-Jun-23 30-Sep-23 VALUATION HIGHLIGHTS¹ NET DEBT TO EBITDA (excl. IFRS 16) GEL million, unless noted otherwise 30-Sep-23 30-Jun-23 Change 31-Dec-22 Change 4.3x 4.1x Enterprise value 645.4 680.8 (35.4) 653.3 (8.0) LTM EBITDA 51.7 52.9 (1.3) 53.6 (1.9) Implied EV/EBITDA multiple 12.5x 12.9x (0.4x) 12.2x 0.3x Net debt incl. lease liabilities (231.0) (222.2) (8.8) (188.1) (42.9) Equity value of GCAP's share 381.9 426.1 (44.2) 433.2 (51.3) 30-Jun-23 30-Sep-23 <2.5x TARGET Georgia Capital PLC | 1. The independent valuations of the large and investment portfolio companies are performed on a semi-annual basis. In 3Q23, our private large and investment portfolio companies were valued internally by incorporating 3Q23 results, in line with IPEV guidelines and methodology deployed in 1H23 by a third-party independent valuation firm. GEORGIA CAPITAL COM 300 57 44

View entire presentation